These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5553382)

  • 1. Labilizing affect of lipoprotein lipase on lysosomes of tumor cells.
    Niitani H; Taniguchi T; Inagaki J; Kimura K
    Gan; 1971 Feb; 62(1):61-3. PubMed ID: 5553382
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences of lysosomal membranes stabilities recognized between tumor cells and non-tumor cells against lysosome labilizers.
    Taniguchi T; Niitani H; Saijo N; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1976 Jun; 11(2):218-26. PubMed ID: 987123
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental study on role of lysosomes in cancer chemotherapy.
    Inagaki J
    Nagoya J Med Sci; 1977 Mar; 39(3-4):43-58. PubMed ID: 887141
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of lysosomes in cancer chemotherapy. I. A study of lysosomal enzymes in Yoshida ascites sarcoma cells.
    Suzuki A; Niitani H; Shimoyama M; Kimura K
    Gan; 1966 Apr; 57(2):185-92. PubMed ID: 5959698
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical changes in tumor cells caused by antitumor agents. II. Effect of several antitumor agents in vivo and in vitro on beta-glucuronidase and two other lysosomal enzymes of Yoshida sarcoma cells.
    Aoshima M; Tsukagoshi S; Sakurai Y
    Gan; 1966 Jun; 57(3):279-86. PubMed ID: 5962638
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of lysosomes in cancer chemotherapy. II. Effect of mitomycin-C injection on lysosomal enzymic activities of Yoshida ascites sarcoma cells.
    Niitani H; Suzuki A; Shimoyama M; Kimura K
    Gan; 1966 Apr; 57(2):193-200. PubMed ID: 5959699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of combined therapy with lysosome labilizer and antineoplastic agents with reference to increased effect of mitomycin C by lipoprotein lipase].
    Niitani H; Inagaki J; Taniguchi T; Shimoyama M; Konda C
    Saishin Igaku; 1970 Jan; 25(1):172-6. PubMed ID: 4245860
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical changes in tumor cells caused by antitumor agent. IV. Influence of antitumor agent on isozyme pattern of beta-glucuronidase.
    Aoshima M; Sakurai Y
    Gan; 1969 Apr; 60(2):129-35. PubMed ID: 5810958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical studies on cancer chemotherapy--enhancement of the cytocidal effect of Mitomycin-C by one of lysosome labilizer, plasmin].
    Taniguchi T
    Nihon Gan Chiryo Gakkai Shi; 1972 Dec; 7(4):290-309. PubMed ID: 4266268
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical changes in tumor cells caused by antitumor agents. 3. Further studies on the effects of antitumor agent on nad'ase and a few lysosomal enzymes of Yoshida sarcoma cells.
    Aoshima M; Tsukagoshi S; Sakurai Y
    Gan; 1967 Feb; 58(1):75-84. PubMed ID: 4293127
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological studies on Yoshida sarcoma cells. I. The effect of heterologous anti-Yoshida sarcoma cell antibodies on the lysosomal acid DNase of sarcoma cells.
    Kuroyanagi T; Sugiyama H
    Jpn J Exp Med; 1970 Jun; 40(3):183-90. PubMed ID: 5312120
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of lysosomes in cancer chemotherapy. 3. Influence of plasmin on the lysosomes of tumor cells and on the cytocidal effect of mitomycin-C.
    Shimoyama M; Niitani H; Taniguchi T; Inagaki J; Kimura K
    Gan; 1969 Feb; 60(1):33-9. PubMed ID: 4238525
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-glucuronidase activity of Yoshida ascites hepatomas of different drug-sensitivity and its change after treatment of host rats with various anticancer agents.
    Abe I; Sato S
    Gan; 1976 Feb; 67(1):55-65. PubMed ID: 57896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of actinomycin D on the activity of enzymes in rat liver lysosomes].
    Pokrovskiĭ AA; Kravchenko LV; Tutel'ian VA
    Dokl Akad Nauk SSSR; 1970; 192(5):1170-3. PubMed ID: 5470182
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon enhances the fragility of lysosomes in L-929 mouse fibroblasts.
    Halbach M; Koschel K; Jungwirth Ch
    J Gen Virol; 1978 May; 39(2):387-90. PubMed ID: 418151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes induced by 2-acetylaminofluorene in lysosomes in rat liver parenchymal cells.
    Berg T; Christoffersen T
    Biochem Pharmacol; 1974 Dec; 23(23):3323-9. PubMed ID: 4441419
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of the effects of antitumor agents on lysosomes of tumor in vivo.
    Filov VA; Tretyakov AV; Ryazanov EM
    Biochem Pharmacol; 1978 May; 27(9):1381-2. PubMed ID: 697940
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chronic ethanol treatment on rat liver lysosomes.
    Berg T; Morland J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):409-16. PubMed ID: 4801085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzymatic heterogeneity of lysosomes].
    Pokrovskiĭ AA; Kravchenko LV; Tutel'ian VA; Doronin NN
    Dokl Akad Nauk SSSR; 1972 Aug; 205(6):1483-6. PubMed ID: 4344019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of antineoplastic agents on the activity and molecular heterogeneity of lysosomal hydrolases in Ehrlich ascites tumor].
    Filov VA; Tret'iakov AV; Riazanov EM
    Dokl Akad Nauk SSSR; 1974 Aug; 217(4):961-4. PubMed ID: 4211407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.